Literature DB >> 14684191

Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme.

Maria F Chan1, Karen Schupak, Chandra Burman, Chen-Shou Chui, C Clifton Ling.   

Abstract

This study was designed to assess the feasibility and potential benefit of using intensity-modulated radiotherapy (IMRT) planning for patients newly diagnosed with glioblastoma multiforme (GBM). Five consecutive patients with confirmed histopathologically GBM were entered into the study. These patients were planned and treated with 3-dimensional conformal radiation therapy (3DCRT) using our standard plan of 3 noncoplanar wedged fields. They were then replanned with the IMRT method that included a simultaneous boost to the gross tumor volume (GTV). The dose distributions and dose-volume histograms (DHVs) for the planning treatment volume (PTV), GTV, and the relevant critical structures, as obtained with 3DCRT and IMRT, respectively, were compared. In both the 3DCRT and IMRT plans, 59.4 Gy was delivered to the GTV plus a margin of 2.5 cm, with doses to critical structures below the tolerance threshold. However, with the simultaneous boost in IMRT, a higher tumor dose of approximately 70 Gy could be delivered to the GTV, while still maintaining the uninvolved brain at dose levels of the 3DCRT technique. In addition, our experience indicated that IMRT planning is less labor intensive and time consuming than 3DCRT planning. Our study shows that IMRT planning is feasible and efficient for radiotherapy of GBM. In particular, IMRT can deliver a simultaneous boost to the GTV while better sparing the normal brain and other critical structures.

Entities:  

Mesh:

Year:  2003        PMID: 14684191     DOI: 10.1016/j.meddos.2003.08.004

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.531


  21 in total

1.  Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit.

Authors:  Karl H Rasmussen; Nicholas Hardcastle; Steven P Howard; Wolfgang A Tomé
Journal:  Technol Cancer Res Treat       Date:  2010-08

Review 2.  Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Authors:  Erwin G Van Meir; Costas G Hadjipanayis; Andrew D Norden; Hui-Kuo Shu; Patrick Y Wen; Jeffrey J Olson
Journal:  CA Cancer J Clin       Date:  2010 May-Jun       Impact factor: 508.702

3.  Quasi-VMAT in high-grade glioma radiation therapy.

Authors:  G Fadda; G Massazza; S Zucca; S Durzu; G Meleddu; M Possanzini; P Farace
Journal:  Strahlenther Onkol       Date:  2013-04-04       Impact factor: 3.621

4.  Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).

Authors:  Mariangela Massaccesi; Marica Ferro; Savino Cilla; Mario Balducci; Francesco Deodato; Gabriella Macchia; Vincenzo Valentini; Alessio G Morganti
Journal:  Int J Clin Oncol       Date:  2012-08-15       Impact factor: 3.402

5.  Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Authors:  Shu-Lian Wang; Zhongxing Liao; Helen Liu; Jaffer Ajani; Stephen Swisher; James D Cox; Ritsuko Komaki
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

6.  Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.

Authors:  David Thibouw; Gilles Truc; Aurélie Bertaut; Cédric Chevalier; Léone Aubignac; Céline Mirjolet
Journal:  J Neurooncol       Date:  2018-01-27       Impact factor: 4.130

7.  Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy.

Authors:  Kiyoshi Nakamatsu; Minoru Suzuki; Yasumasa Nishimura; Shuichi Kanamori; Ryuta Koike; Toru Shibata; Naoya Shintani; Masahiko Okumura; Kaoru Okajima; Fumiharu Akai
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

8.  Feasibility and outcomes of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy for malignant gliomas: a preliminary report.

Authors:  Jihye Cha; Chang-Ok Suh; Kwangwoo Park; Jong Hee Chang; Kyu Sung Lee; Se Hoon Kim; Jee Suk Chang; Joo Ho Kim; Yang-Gun Suh; Jun Won Kim; Jaeho Cho
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

9.  Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.

Authors:  Marc D Piroth; Michael Pinkawa; Richard Holy; Gabriele Stoffels; Cengiz Demirel; Charbel Attieh; Hans J Kaiser; Karl J Langen; Michael J Eble
Journal:  Radiat Oncol       Date:  2009-11-23       Impact factor: 3.481

10.  Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.

Authors:  Clifton D Fuller; Mehee Choi; Britta Forthuber; Samuel J Wang; Nancy Rajagiriyil; Bill J Salter; Martin Fuss
Journal:  Radiat Oncol       Date:  2007-07-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.